AI UNITE
Prescribing Decisions
Topical Janus kinase (JAK) inhibitors for atopic dermatitis
The use of topical JAKs will be a game changer. The ability to decrease itch within as little as 12 hours is impressive. Patients and parents are most frustrated by the itch which is not relieved satisfactorily with the available topical options. Having such an effective option will certainly get the longstanding AD patients on board who are usually skeptical of new treatments since they are typically expensive and offer little improvement.